{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:26:07Z","timestamp":1787199967024,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Poly(N-acryloyl glycinamide) (PNAGA) was evaluated as a temperature-responsive carrier for antimalarial drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PNAGA was synthesized and characterized by DSC and TGA, and its sol\u2013gel transition was determined by the reverse test-tube method. Encapsulation efficiency (EE%) of mefloquine hydrochloride and pyrimethamine in PNAGA was determined by UV-Vis spectrophotometry, using dialysis to separate free from encapsulated drug and calibration curves at each drug's characteristic absorbance maximum (284 nm for mefloquine hydrochloride, 272 nm for pyrimethamine). Free drugs and PNAGA-encapsulated formulations were introduced to Plasmodium falciparum cultures, alongside PNAGA alone and a negative control, and parasitemia was assessed after 24 h at 37 \u00b0C and again after 24 h at 4 \u00b0C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DSC and TGA analyses demonstrated PNAGA's amorphous, thermoreversible nature and established its thermal stability limits. The sol\u2013gel transition was 22.6 \u00b0C \u00b1 1 \u00b0C, confirming UCST behavior. PNAGA efficiently encapsulated mefloquine hydrochloride and pyrimethamine, with encapsulation efficiencies of 93.3% and 94.7%, respectively. After 24 h at 37 \u00b0C, parasitemia was significantly lower in cultures treated with free drugs than with polymer-bound formulations, indicating that encapsulation delayed drug release and reduced immediate efficacy. PNAGA alone showed no inhibitory effect. After 24 h at 4 \u00b0C (below the sol\u2013gel transition), PNAGA\u2013mefloquine matched free mefloquine in efficacy, while PNAGA\u2013pyrimethamine remained less effective than free pyrimethamine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings confirm that PNAGA is a reproducible, temperature-responsive hydrogel that efficiently encapsulates antimalarial drugs and modulates their availability according to its UCST, with reduced immediate efficacy at 37 \u00b0C (above the sol\u2013gel transition) and higher efficacy below the sol\u2013gel transition (4 \u00b0C) for PNAGA\u2013mefloquine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1767493","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:16:20Z","timestamp":1787199380000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of free and PNAGA-encapsulated antimalarial drugs: temperature-dependent modulation of Plasmodium falciparum growth"],"prefix":"10.3389","volume":"17","author":[{"given":"Daniel","family":"Mutangadura","sequence":"first","affiliation":[{"name":"Department of Biotechnology and Biochemistry, University of Zimbabwe","place":["Harare, Zimbabwe"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mushonga","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Earth Sciences, University of Zimbabwe","place":["Harare, Zimbabwe"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafira","family":"Mduluza","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Biochemistry, University of Zimbabwe","place":["Harare, Zimbabwe"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1000406","DOI":"10.1371\/journal.pmed.1000406","article-title":"A research agenda to underpin malaria eradication","volume":"8","author":"Alonso","year":"2011","journal-title":"PLoS Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12936-020-3104-4","article-title":"A systematic review of factors affecting adherence to malaria chemoprophylaxis amongst travellers from non-endemic countries","volume":"19","author":"Ahluwalia","year":"2020","journal-title":"Malar. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpddr.2021.06.003","article-title":"Mefloquine as a prophylaxis for malaria needs to be revisited","volume":"17","author":"Ahmad","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/nejmoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12936-025-05355-0","article-title":"Projected uptake of sulfadoxine\u2013pyrimethamine for perennial malaria chemoprevention in children under 2 years of age in nine sub-saharan African countries: an epidemiologically-based 5-year forecast analysis","volume":"24","author":"Audibert","year":"2025","journal-title":"Malar. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41467-017-02603-z","article-title":"Long-acting injectable atovaquone nanomedicines for malaria prophylaxis","volume":"9","author":"Bakshi","year":"2018","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1080\/09205063.2024.2391225","article-title":"Targeted polymeric primaquine nanoparticles: optimization, evaluation, and in-vivo liver uptake for improved malaria treatment","volume":"35","author":"Bhargava","year":"2024","journal-title":"J. Biomaterials Sci. Polym. Ed."},{"key":"B6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2217\/nnm.13.61","article-title":"Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria","volume":"9","author":"Borhade","year":"2014","journal-title":"Nanomedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/gels5010013","article-title":"Poly[(N-acryloyl glycinamide)-co-(N-acryloyl L-alaninamide)] and their ability to form thermo-responsive hydrogels for sustained drug delivery","volume":"5","author":"Boustta","year":"2019","journal-title":"Gels"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2013.10.040","article-title":"Versatile UCST-based thermoresponsive hydrogels for loco-regional sustained drug delivery","volume":"174","author":"Boustta","year":"2014","journal-title":"J. Control. Release"},{"key":"B9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0169-409x(97)00121-x","article-title":"Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery","volume":"31","author":"Bromberg","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/373049a0","article-title":"Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH","volume":"373","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/aac.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob. Agents Chemother. (Bethesda)."},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD011444","DOI":"10.1002\/14651858.CD011444.pub3","article-title":"Mefloquine for preventing malaria in pregnant women","volume":"11","author":"Gonz\u00e1lez","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"23909","DOI":"10.3390\/ijms151223909","article-title":"PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release","volume":"15","author":"Halayqa","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/pol.1970.150080509","article-title":"Synthetic thermally reversible gel systems. III","volume":"8","author":"Haas","year":"1970","journal-title":"J. Polym. Sci. A Polym. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejpb.2007.02.025","article-title":"Thermoresponsive hydrogels in biomedical applications","volume":"68","author":"Klouda","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.34297\/ajbsr.2020.08.001236","article-title":"Correlation between in-vitro and in-vivo studies based on pharmacokinetic considerations","volume":"8","author":"Levy","year":"2020","journal-title":"Am. J. Biomed. Sci. and Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.2147\/IJN.S245188","article-title":"Artemisinin loaded mPEG-PCL nanoparticle based photosensitive gelatin methacrylate hydrogels for the treatment of gentamicin induced hearing loss","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12936-022-04279-3","article-title":"Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009\u20132011: a randomized controlled trial and brief review","volume":"21","author":"Lek","year":"2022","journal-title":"Malar. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41428-023-00798-1","article-title":"Printable Poly(N-acryloyl glycinamide) nanocomposite hydrogel formulations","volume":"55","author":"Majstorovi\u0107","year":"2023","journal-title":"Polym. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12936-024-04851-z","article-title":"Progress towards malaria elimination in the Greater Mekong Subregion: perspectives from the World Health Organization","volume":"23","author":"Manzoni","year":"2024","journal-title":"Malar. J."},{"key":"B19","volume-title":"Methods in Malaria Research","author":"Moll","year":"2013"},{"key":"B20","article-title":"Biomaterials-based hydrogels for therapeutic applications","volume-title":"Biomaterials in Microencapsulation","author":"Musuc","year":"2024"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/MA13173713","article-title":"Preparation of doxorubicin-loaded amphiphilic poly(D, L-Lactide-Co-Glycolide)-b-Poly(NAcryloylmorpholine) AB2 miktoarm star block copolymers for anticancer drug delivery","volume":"13","author":"Ramesh","year":"2020","journal-title":"Materials"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1186\/s12936-020-3104-4","article-title":"Compliance with primary malaria chemoprophylaxis: Is weekly prophylaxis better than daily prophylaxis?","volume":"14","author":"Rodrigo","year":"2020","journal-title":"Patient. Prefer. Adher."},{"key":"B22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12936-020-03336-z","article-title":"Pathophysiology and neurologic sequelae of cerebral malaria","volume":"19","author":"Schiess","year":"2020","journal-title":"Malar. J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1335842","DOI":"10.3389\/fddsv.2023.1335842","article-title":"Editorial: advances in anti-malarial drug discovery","volume":"3","author":"Singh","year":"2023","journal-title":"Front. Drug Discov."},{"key":"B24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2007.06.035","article-title":"Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine","volume":"347","author":"Singh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1021\/ja01161a527","article-title":"The preparation of acrylyl chloride","volume":"60","author":"Stempel","year":"1950","journal-title":"J. Am. Chem. Soc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"CD006491","DOI":"10.1002\/14651858.CD006491.pub4","article-title":"Mefloquine for preventing malaria during travel to endemic areas","volume":"10","author":"Tickell-Painter","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2005.09.005","article-title":"Mobility of model proteins in hydrogels composed of oppositely charged dextran microspheres studied by protein release and fluorescence recovery after photobleaching","author":"Van Tomme","year":"2005","journal-title":"J. Control. Release"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.01.057","article-title":"In situ gelling hydrogels for pharmaceutical and biomedical applications","volume":"355","author":"Van Tomme","year":"2008","journal-title":"Int. J. Pharm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"120617","DOI":"10.1016\/j.ijpharm.2021.120617","article-title":"Paeonol-loaded PLGA nanoparticles as an oral drug delivery system: design, optimization and evaluation","volume":"602","author":"Wang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"B29","volume-title":"World Malaria Report 2022","year":"2022"},{"key":"B30","article-title":"World malaria report 2025","year":"2025"},{"key":"B31","volume-title":"Guidelines for the Treatment of Malaria World Health Organization","year":"2010"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10540","DOI":"10.1039\/c8cc04614j","article-title":"Poly(N-acryloyl glycinamide): a fascinating polymer that exhibits a range of properties from UCST to high-strength hydrogels","volume":"5475","author":"Xu","year":"2018","journal-title":"Chem. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.18063\/ijb.709","article-title":"3D-printed PNAGA thermosensitive hydrogelbased microrobots: an effective cancer therapy by temperature-triggered drug release","volume":"9","author":"Zhou","year":"2023","journal-title":"Int. J. Bioprinting"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1767493\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:16:22Z","timestamp":1787199382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1767493\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":39,"alternative-id":["10.3389\/fphar.2026.1767493"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1767493","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1767493"}}